Found 89 matching trials
Feasibility Trial of Glofitamab in a Response Adapted Approach Incorporating Interim FDG PET and ctDNA to Optimize Primary Therapy of DLBCL (GRAIL) PHASE2 This is a phase ll study of participants with untreated diffuse large B Cel...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP PHASE2 In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Show More Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Learn More & Join Trial
LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure PHASE2 This study evaluates a personalized treatment strategy for patients with la...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Learn More & Join Trial
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL PHASE2 This is a prospective, open-label, multicenter, randomized controlled study...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors PHASE2 The aim of this study is to evaluate the efficacy and safety of CAR T-cell ...
Show More Location
Shanghai Ruijin Hospital
Learn More & Join Trial
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma PHASE2 The goal of this clinical trial is to see if a new combination of standard ...
Show More Location
Townsville University Hospital
Learn More & Join Trial
CAR-T Followed by Bispecific Antibodies PHASE2 The research study is being conducted to test the safety and effectiveness ...
Show More Location
University of Nebraska Medical Center
Learn More & Join Trial
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas PHASE1 The purpose of this study is to evaluate the safety, tolerability, drug lev...
Show More Location
Mayo Clinic in Arizona - Phoenix
Learn More & Join Trial
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma PHASE2 This phase II trial tests the safety and effectiveness of glofitamab given ...
Show More Location
University of California, Davis
Learn More & Join Trial